CarepathRx

Company Overview

CarepathRx is a leading provider of integrated pharmacy services designed to help health systems improve patient outcomes, expand access to care, and manage the rising complexity and cost of medications. Founded in 2019 in partnership with management, the company was purpose-built to create a comprehensive pharmacy platform that spans specialty pharmacy, infusion services, telepharmacy, and advanced medication management solutions across the full continuum of care.

CarepathRx partners closely with health systems to deliver pharmacy services that are clinically integrated, operationally efficient, and aligned with value-based care models. Its platform combines nationwide pharmacy dispensing capabilities, clinical expertise, and purpose-built technology that enables connectivity to provider electronic health records and supports consistent, high-quality pharmacy care from hospital to home. With broad pharmacy licensure and a growing national footprint, CarepathRx provides its patients and customers the scale, infrastructure, and confidence to expand pharmacy services while maintaining clinical and operational control.

Led by an experienced management team with a strong track record in building and scaling innovative pharmacy care models, CarepathRx has rapidly grown and manages many billions of dollars in annual drug revenue across the enterprise. The company’s differentiated model positions pharmacy not as a standalone function, but as a strategic asset for health systems seeking to improve quality of care, patient experience, and financial performance in an increasingly complex healthcare environment.

Deal Background

CarepathRx was formed in 2019 in partnership with management from Nautic’s Executive Network to capitalize on structural changes reshaping the pharmacy services market. Increasing specialty drug utilization, rising total cost of care, and growing pressure on health systems to deliver better outcomes at lower cost created a compelling opportunity to build a scaled, integrated pharmacy services platform aligned with health system needs.

After a thorough evaluation of potential acquisition targets, Nautic and management established CarepathRx through the initial acquisition of ProHealth and a transformational strategic transaction with UPMC in 2020, creating immediate scale and a broad foundation of clinical and operational capabilities. This platform approach was designed to deliver a complete suite of pharmacy services, supported by national infrastructure, robust technology, and deep clinical expertise.

The business was further expanded through a series of strategic acquisitions, including PipelineRx and Semita Health, which enhanced telepharmacy, enterprise pharmacy management, and technology capabilities. CarepathRx also pursued novel partnership structures, including with Cigna Evernorth, through a strategic partnership and minority equity investment. Collectively, these initiatives enabled the company to establish a national footprint, offer integrated pharmacy solutions, and support value-based pharmacy care arrangements for health system partners.

Nautic Value-Add

Throughout its ownership period, Nautic worked closely with management to build CarepathRx into a high-quality, scaled pharmacy services platform. A key early focus was assembling a best-in-class leadership team, led by Founder, Chairman, and CEO John Figueroa, whose prior experience scaling innovative pharmacy models provided strong strategic and operational leadership from inception.

Nautic actively supported the execution of M&A to help build the strategy, including the integration of multiple businesses to create an end-to-end pharmacy services offering. This included expanding enterprise pharmacy management capabilities, improving the procurement function, enhancing technology and data infrastructure, and ensuring interoperability with provider electronic health records. These efforts sought to position
CarepathRx as a partner to health systems and enable participation in increasingly complex value-based pharmacy care arrangements.

In parallel, Nautic played a key role in guiding capital allocation and strategic decision-making, seeking to balance near-term value realization with long-term upside. Across all initiatives, Nautic remained focused on building a durable, scalable business by emphasizing operational excellence, strategic partnerships, and alignment with health system customers.

Certain statements about Nautic made by portfolio company executives herein are intended to illustrate Nautic’s business relationship with such persons, including with respect to Nautic’s facilities as a business partner, rather than Nautic’s capabilities or expertise with respect to investment advisory services. Portfolio company executives were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company roles, and in certain cases are also owners of portfolio company securities and/or investors in Nautic-sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.